Check-Cap Ltd. (CHEK)
undefined
undefined%
At close: undefined
0.63
0.00%
After-hours Dec 13, 2024, 03:24 PM EST

Company Description

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel.

Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.

The company was incorporated in 2004 and is based in Isfiya, Israel.

Check-Cap Ltd.
Check-Cap Ltd. logo
Country IL
IPO Date Mar 4, 2015
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 85
CEO Dr. Yoav Kimchy Ph.D.

Contact Details

Address:
Check-Cap Building
Isfiya,
IL
Website https://www.check-cap.com

Stock Details

Ticker Symbol CHEK
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001610590
CUSIP Number M2361E203
ISIN Number IL0011336851
Employer ID 00-0000000
SIC Code 3844

Key Executives

Name Position
David Benaim Interim Chief Financial Officer
Dr. Yoav Kimchy Ph.D. Founder, Head of R&D and Member of Scientific Advisory Board
Noa Reshef M.B.A. Head of Operations

Latest SEC Filings

Date Type Title
Dec 03, 2024 6-K Filing
Sep 13, 2024 6-K Filing
Aug 05, 2024 6-K Filing
May 15, 2024 20-F Filing
May 01, 2024 NT 20-F Filing
Apr 29, 2024 6-K Filing
Apr 15, 2024 6-K Filing
Apr 10, 2024 6-K/A [Amend] Filing
Apr 08, 2024 SC 13D/A [Amend] Filing
Apr 08, 2024 6-K Filing